Abstract-ATP leads to endothelial NO synthase (eNOS)/NO-mediated vasodilation, a process hypothesized to depend on the endothelial caveolar eNOS partitioning and subcellular domain-specific multisite phosphorylation state. We demonstrate herein that, in both the absence and presence of ATP, the uterine artery endothelial caveolae contain specific protein machinery related to subcellular partitioning and act as specific focal "hubs" for NO-and ATP-related proteins. ATP-induced eNOS regulation showed a complex set of multisite posttranslational phosphorylation events that were closely associated with the enzyme's partitioning between caveolar and noncaveolar endothelial subcellular domains. The comprehensive model that we present demonstrates that ATP repartitioned eNOS between the caveolar and noncaveolar subcellular domains; specifically, the stimulatory PSer635 eNOS was substantially higher in the caveolar pool with subcellular domain-independent increased levels on ATP treatment. The stimulatory PSer1179 eNOS was not altered by ATP treatment. However, the inhibitory PThr495 eNOS was regulated predominantly in the caveolar domain with decreased levels on ATP action. In contrast, the agonist-specific PSer114 eNOS was localized in the noncaveolar pool with increased levels on ATP stimulation. Thus, the endothelial caveolar membrane system plays a pivotal role(s) in ATP-associated subcellular partitioning and possesses the relevant protein machinery for ATP-induced NO regulation. Furthermore, these subcellular domain-specific phosphorylation/dephosphorylation events provide evidence relating to eNOS spatio-temporal dynamics. Under resting unstimulated conditions, eNOS is primarily located in specialized protein-rich plasmalemmal invaginations called caveolae, where its activity is inhibited by direct binding to the scaffolding protein caveolin (cav) 1.
Under resting unstimulated conditions, eNOS is primarily located in specialized protein-rich plasmalemmal invaginations called caveolae, where its activity is inhibited by direct binding to the scaffolding protein caveolin (cav) 1.
14 However, treatment with calcium-mobilizing agonists leads to eNOS translocation from the caveolar membrane into other intracellular sites. [15] [16] [17] The dynamics of subcellular protein partitioning led us to investigate the entire caveolar proteome using mass spectrometry in the absence and presence of extracellular ATP.
Endothelial cell eNOS activation is further modulated by posttranslational modification via multisite phosphorylation/ dephosphorylation. 11 However, the sequential modifications of the multisite phosphorylation state of eNOS within the caveolar and noncaveolar subcellular domains are unknown. Interestingly, eNOS protein possesses multiple phosphorylation sites, including Ser1179 and Ser635, which are stimulatory; Thr495, which is inhibitory; and Ser114, which is stimulatory or inhibitory depending on the agonist used. 18, 19 Although several excellent review articles 11, 14, 17, 20, 21 have theorized the complex interaction between eNOS partitioning and its phosphorylation/dephosphorylation status, no study has been performed to directly test this hypothesis. Therefore, we hypothesized that posttranslational phosphorylation/dephosphorylation of eNOS is intimately associated with its partitioning in endothelial cells. In addition, subcellular domain-specific multisite phosphorylation/dephosphorylation would occur on ATP stimulation.
We demonstrate herein that the caveolae contain a rich protein machinery relating to a myriad of biological and cellular processes with at least a quarter of the proteome directly relating to subcellular localization or partitioning. We further show that, independent of the ATP effects, the endothelial caveolar subcellular microdomains act as specific focal hubs for NO-and ATP-related proteins. Our findings additionally demonstrate for the first time that ATP stimulates eNOS phosphorylation/dephosphorylation in a site-and subcellular domain-specific manner.
Methods
For complete details on specific methods, please see the online-only Data Supplement.
Results
To assess the effect of the calcium-mobilizing agonist ATP on the uterine artery endothelial caveolar protein machinery, we performed liquid chromatography-tandem mass spectroscopy analyses on enriched caveolar fractions obtained from sucrose density gradient centrifugation of endothelial cells treated with or without ATP (100 mol/L; 5 minutes). We have described previously the endothelial caveolar enrichment process and validated the protocol used in this article with electron microscopy analysis, as well as a caveolae-specific antibody panel. 22 In addition, to validate the cell preparations used in the current study, we performed Western blotting using commercially available ovine antibodies for cav-1, 23 cav-2, 16 eNOS, 11 and heat shock protein (HSP) 90 14 ( Figure 1A ). The presence of the classic caveolar proteins cav-1 and eNOS in the proteome (Table S1 , available in the online-only Data Supplement) was validated by Western immunoblotting. As expected, Western blotting showed low expression of cav-2, whereas HSP90 was barely detectable in the caveolar domain and was almost exclusively found only in the noncaveolar domain confirming the proteomic observations that cav-2 and HSP90 were not detectable among the 75 most enriched caveolar proteins that were examined in this study.
The entire caveolar proteome in the control and ATP treatment groups were populated in Scaffold proteomic soft- ware version 2.06.02 and classified based on the cellular and biological processes that they were involved in. First, the caveolar proteins that had a Gene Ontology term listed in the National Center for Biotechnology Information database were classified according to cellular processes ( Figure 1B) ; Ϸ38% and 30% of the endothelial caveolar proteins were associated with molecular function and protein-protein binding, respectively. The large number of proteins associated with binding probably demonstrates that the caveolae were rich in proteins that may directly regulate subcellular partitioning. The caveolae were also abundant (16.1%) in proteins associated with catalysis. In contrast, proteins associated with all of the other cellular processes, including caveolar structure, transport, molecular transduction, enzyme regulation, translation regulation, electron transport, transcription regulation, and motor activity together composed only 15.6% of the caveolar proteome. We then classified the endothelial caveolar proteome according to biological processes ( Figure  1C ). More than half of the proteome was associated with basic cellular processes and metabolism. A quarter of the proteome related to subcellular localization, validating the percentage fraction of proteins associated with binding observed in Figure 1B . Proteins related to all of the other biological processes, including biological regulation, stimulus response, multicellular organismal processes, developmental processes, adhesion, locomotion, immune system, and growth, collectively constituted only 15.5% of the caveolar proteome. Further classification of the 75 most enriched proteins in the caveolae showed that 56.3% of the proteins were related to NO or ATP (ATPases, ATP synthases, and ATP transporters; Figure 2A ). Substratification of these proteins revealed that NO-related proteins composed Ϸ40% of the caveolar proteome, whereas Ϸ17% were ATP related. Analysis of normalized enrichment score, an estimate of the enrichment of proteins in each category, did not reveal a main effect of ATP treatment. However, independent of ATP effect, the caveolae were significantly more enriched for NO-related (PϽ0.001), ATP-related (PϽ0.001), and cell function-related (PϽ0.005) proteins compared with all of the other categories ( Figure 2B ). These results demonstrate the substantial importance of ATP-induced NO signaling in the caveolar subcellular domains. Following our observations on the eNOS-and ATPassociated proteins in these caveolar subcellular domains, we then studied the effect of the calcium mobilizing agonist ATP on eNOS multisite phosphorylation using Western blotting on whole endothelial cell lysates. Total cav-1, total eNOS, and GAPDH were not different between control and ATP treatment groups ( Figure 3A) . However, ATP treatment differentially altered the eNOS multisite phosphorylation state (Figure 3B) . Specifically, stimulatory PSer635 eNOS was significantly (PϽ0.05) increased, whereas the stimulatory PSer1179 eNOS was unaltered. In contrast, the inhibitory PThr495 eNOS was significantly (PϽ0.05) decreased in response to ATP compared with the control group. Regulated phosphorylation also occurred at the agonist-specific site Ser114;
PSer114 eNOS was significantly (PϽ0.05) increased in response to ATP treatment.
We then examined the subcellular domain-specific multisite phosphorylation/dephosphorylation state of eNOS. Cav-1 immunoisolation showed that, on ATP treatment, eNOS bound to cav-1 significantly (PϽ0.05) decreased by 46.6%, and the ratio of eNOS to cav-1 significantly (PϽ0.05) decreased by 55.8% (data not shown). Subsequently, we 
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N O -r e la t e d A T P -r e la t e d T r a n s p o r t E n z y m e C e ll f u n c t io n S t r u c t u r e H is t o n e performed subcellular domain-specific immunoblot analyses on the enriched caveolar and noncaveolar fractions obtained from sucrose density gradient centrifugation ( Figure  4 ). In control unstimulated endothelial cells, stimulatory PSer635 eNOS was significantly (PϽ0.05) more abundant in the caveolar domain compared with the noncaveolar pool. Furthermore, PSer635 eNOS was significantly (PϽ0.05) greater in the ATP group compared with the control group. These data directly validated the whole cell observations. Neither an effect of the subcellular domain nor an effect of ATP was observed with PSer1179 eNOS, again confirming the whole endothelial cell data. The inhibitory PThr495 eNOS exhibited a strong trend (0.05 Ͻ PϽ0.1) with an interaction between the factors subcellular domain and ATP treatment. However, when the absorbance values were individually divided by their total eNOS protein expression level, a main effect of subcellular domain was detected, with PThr495 eNOS being detected predominantly only in the caveolar domain and ATP effect still trending lower toward significance. In contrast, 2 bands (one at the level of whole eNOS and the other at Ϸ220 kDa) were detected for PSer114 eNOS, confirming the bands observed at the whole cell level ( Figure 3B 
Discussion
We demonstrate herein that the caveolae contain a rich protein machinery relating to a myriad of biological and cellular processes with at least a quarter of the proteome directly relating to subcellular localization or partitioning. We also show that, independent of the effect of ATP, the endothelial caveolar subcellular microdomains act as specific focal hubs of NO-and ATP-related proteins. The dynamics of ATP-induced eNOS regulation further show, as illustrated in Figure 5 , a complex set of multisite posttranslational phosphorylation events that are closely associated with the partitioning of an enzyme between caveolar and noncaveolar endothelial subcellular domains.
We report for the first time that a quarter of the endothelial caveolar proteome related to subcellular localization when classified based on the biological processes in which the proteins were involved. These numbers were also similar to the fraction of proteins (30%) related to protein-protein binding when classified based on cellular processes. These data demonstrate the pivotal role of the caveolae in subcellular protein partitioning to achieve directed physiological signaling and also support numerous studies that have investigated the caveolae for localization-based protein function regulation. 14, 24 In addition to these findings, our data also demonstrate that the caveolae contain numerous proteins related to basic cellular processes and metabolism.
Our data demonstrate that, with or without the calciummobilizing agonist ATP, the endothelial caveolae contain a rich protein machinery related to the vasodilator NO. These proteins included those related to eNOS trafficking, cell-cell adhesion, and those directly involved in NO metabolism. Prominent eNOS trafficking-associated proteins detected in the endothelial caveolae include filamin and tubulin. This is supportive of earlier reports on a role for filamin and tubulin in facilitating eNOS-HSP90 interaction and subsequent trafficking in and out of the caveolae. 25, 26 Consistent with other studies, herein we detected numerous adhesion proteins, including platelet endothelial cell adhesion molecule and vascular endothelial cadherin, proteins that play a critical role in NO regulation in the endothelial caveolae. [27] [28] [29] Finally, we detected a host of proteins directly related to NO metabolism, including eNOS and cav-1. PSer1179 eNOS was unaltered. The inhibitory PThr495 eNOS was significantly decreased in response to ATP. The agonist-specific PSer114 eNOS was significantly increased in response to ATP treatment.
We observed that the caveolar system is also the "home" for many ATP-related proteins that include ATPases, ATP synthases, and ATP transporters. The current study provides definitive evidence that these mitochondrial and endoplasmic reticulum proteins can actually be enriched from the caveolae, a finding consistent with earlier reports. [29] [30] [31] In addition, the presence of these proteins in the caveolae has also been attributed to the physical interaction between these organelles with the caveolae at specific contact sites, termed as mitochondria-associated endoplasmic reticulum membranes and plasma membrane-associated endoplasmic reticulum membranes. 30 As expected, we observed that ATP treatment resulted in significant dissociation of total eNOS from cav-1, a finding consistent with the idea that calcium-mobilizing agonist stimulation leads to eNOS translocation from the caveolar subcellular compartment into the noncaveolar domain. 15, 32 In the present study, we also demonstrated PThr495 eNOS being detected predominantly only in the caveolar domain and ATP effect trending lower toward significance. D, Two bands (one at the level of whole eNOS and the other at Ϸ220 kDa) were detected for PSer114 eNOS, confirming the observations at the whole cell level. These findings were confirmed in a replicate blot and are both depicted in the figure. No bands were detected in the caveolar domain, demonstrating that PSer114 eNOS was restricted to the noncaveolar pool. However, because of the low expression of the band at 140 to 150 kDa, quantitative analysis was not performed for PSer114 eNOS subcellular domain-specific levels. In certain cases, gels were run in replicates and were used for quantification.
that ATP leads to significant phosphorylation and dephosphorylation of specific residues in the eNOS protein. The sequential subcellular domain-specific alteration in the phosphorylation of the enzyme is depicted in Figure 5 . ATP significantly increased the phosphorylation of whole endothelial cell PSer635 eNOS. Subcellular domain-specific analysis further demonstrated a significant main effect of both subcellular domain and ATP treatment. This site is phosphorylated to a much greater extent in the caveolar pool of the enzyme compared with the noncaveolar domain. Moreover, the PSer635 eNOS phosphorylation level is significantly higher on ATP stimulation. Ser635 is a welldocumented protein kinase A-dependent excitatory phosphorylation site localized in the flavin mononucleotidebinding domain. 18, 33 Although information regarding subcellular domain-specific alterations of this site is lacking, it has been reported that phosphorylation on Ser635 peaks between 5 and 10 minutes with sustained levels Յ30 minutes 34 and that this site is important for sustained NO production independent of intracellular calcium transients. 18, 35 Collectively, these data demonstrate that PSer635 eNOS phosphorylation is an important subcellular domain-specific posttranslational modification that appears to play a pivotal role in sustained ATP-induced eNOS activation. We also observed that neither at the whole endothelial cell level nor at the subcellular level was PSer1179 eNOS altered with ATP treatment. Ser1179 is an extensively studied AKT-dependent site. 18 However, the lack of subcellular domain-specific alteration of this enzyme is consistent with earlier studies that did not show a role for AKT in ATP signaling. 36 Moreover, our data demonstrate that phosphorylation at this site is also not related to the location of the enzyme and that ATP-induced eNOS excitatory phosphorylation exhibits specificity by acting via the Ser635 site.
The current data for inhibitory PThr495 eNOS exhibited a strong trend (0.05 Ͻ PϽ0.1) with an interaction between the factors subcellular domain and ATP treatment. However, when the absorbance values were individually divided by their total eNOS protein expression level, a main effect of the subcellular domain was detected, with PThr495 eNOS being detected predominantly only in the caveolar domain and ATP effect still trending toward significance. These data are consistent with the previous reports that protein kinase C-dependent Thr495 phosphorylation inhibits eNOScalmodulin interaction and subsequent repartitioning of the enzyme into the noncaveolar domain and that its dephosphorylation by ATP significantly contributes to elevated eNOS activity. 18, 34 However, our current study is the first to demonstrate that Thr495 is not phosphorylated in the noncaveolar domain, demonstrating that dephosphorylation on this site is subcellular-domain specific.
At the whole cell level, PSer114 eNOS level was significantly greater on ATP treatment compared with the control group. At the subcellular level, however, no bands were detected in the caveolar fractions. However, quantification of the bands observed in the noncaveolar fractions could not be performed, because 2 bands were detected, one at 140 to 150 kDa and the other at Ϸ220 kDa, and the lower band was too low for quantification. Taking together the absence of bands in the caveolar domain and the significant increase in their levels in whole endothelial cell preparations, we conclude that, unlike PThr495 eNOS, PSer114 eNOS regulation is restricted only to the noncaveolar domain and is phosphorylated on ATP treatment. Ser114 is the only known phosphorylation site in the oxygenase domain of the eNOS enzyme, and the function of this site is agonist specific, with VEGF promoting Ser114 dephosphorylation and shear stress phosphorylating this site. 18 Because myristoylation and palmitoylation all occur in the amino acid residues that are localized in the eNOS oxygenase domain, 14, 37 we reason that phosphorylation of noncaveolar Ser114 must prevent eNOS trafficking back to the caveolae on ATP stimulation.
Perspectives
In summary, the endothelial actions of the physiological vasodilator ATP are mediated through caveolar microdomains that possess the relevant protein machinery for eNOS-NO regulation. The current study directly infers the cause-and-effect relationship between eNOS subcellular partition and multisite phosphorylation; thus, these data underpin the intimate relationship between these 2 factors in NO regulation. Furthermore, the subcellular domain-specific multisite phosphorylation state of eNOS illustrates a unique role for each of the regulatory amino acid residues in eNOS regulation that is intimately associated with the intracellular location and/or trafficking of the enzyme, thus providing for the first time direct spatio-temporal indications to eNOS activation states.
